A Smoking Cessation Programme in HIV-Infected Individuals: A Pilot Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Antiretroviral therapy (ART) is a risk factor for cardiovascular disease (CVD) and smoking the most important modifiable cardiovascular risk factor. Methods: We prospectively evaluated a smoking cessation programme (SCP) in HIV-infected individuals (intervention: counselling and nicotine replacement therapy). Primary endpoint was the smoking cessation rate at 12 months; secondary endpoints were CVD morbidity and mortality. Controls were a not randomized control group of smokers not participating in the SCP. Results: Four-hundred and seventeen of 680 (61%) patients were smokers, and 34 of these participated in the SCP. Of these 34 individuals, 82% were male, the median age was 43 years, prior AIDS was recorded in 29%, and depressive disorder was recorded in 18%. Twenty-five (74%) patients were receiving ART. Additional risk factors were dyslipidaemia (68%), a prior cardiovascular event (24%), hypertension (15%), and a family history of CVD in 2/34 (6%) individuals. According to the Framingham equation, the 10-year risk of CVD was higher in SCP participants than in controls (11.2% versus 8.5%, P=0.06). At termination of the SCP, 17/34 (50%) individuals had stopped smoking compared with 57/383 (15%) controls. Self-reported smoking abstinence for ≥12 months was 13/34 (38%) in the intervention group and 27/383 (7%) in the control group (odds ration 6.2, 95% confidence interval 2.8–14.3). During the follow-up, two SCP participants and 4 controls experienced a myocardial infarction. One patient in the control group died of CVD. Conclusions: SCP in HIV-infected individuals is feasible and should be encouraged. The long-term impact of smoking cessation on CVD morbidity and mortality should be evaluated in comparative trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physician advice for smoking cessation
Stead, L. F., Buitrago, D., Preciado, N., Sanchez, G., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000165.pub4 · Cited by 1,955
Cigarette Smoking and Infection
Arcavi, L., & Benowitz, N. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2206 · Cited by 1,020
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2005) · Diabetes Care · doi:10.2337/diacare.28.suppl_1.s37 · Cited by 830
Smoking cessation with and without assistance
Zhu, S.-H., Melcer, T., Sun, J., Rosbrook, B., & Pierce, J. P. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00124-0 · Cited by 405
Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now
Niaura, R., Shadel, W. G., Morrow, K., Tashima, K., Flanigan, T., & Abrams, D. B. (2000) · Clinical Infectious Diseases · doi:10.1086/314048 · Cited by 176
Effective tobacco dependence treatment
Fiore, M. C. (2002) · JAMA · doi:10.1001/jama.288.14.1768 · Cited by 97 · cited 1×
“Hence, patients wishing to stop should be offered specific assistance and follow-up [32,34].”
Trends in risk factors for the major “lifestyle-related diseases” in Geneva, Switzerland, 1993–2000
Galobardes, B., Costanza, M. C., Bernstein, M. S., Delhumeau, C. H., & Morabia, A. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00055-3 · Cited by 34
Cited by
Lewden, C., May, T., Rosenthal, E., Burty, C., Bonnet, F., Costagliola, D., Jougla, E., Semaille, C., Morlat, P., Salmon, D., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817efb54 · Cited by 342
Lifson, A. R., Neuhaus, J., Arribas, J. R., van den Berg-Wolf, M., Labriola, A. M., Read, T. R. H., & for the INSIGHT SMART Study Group (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.188664 · Cited by 281
Smoking Among HIV Positive New Yorkers: Prevalence, Frequency, and Opportunities for Cessation
Tesoriero, J. M., Gieryic, S. M., Carrascal, A., & Lavigne, H. E. (2010) · AIDS and Behavior · doi:10.1007/s10461-008-9449-2 · Cited by 278
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial
Lloyd‐Richardson, E. E., Stanton, C. A., Papandonatos, G. D., Shadel, W. G., Stein, M., Tashima, K., Flanigan, T., Morrow, K., Neighbors, C., & Niaura, R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02623.x · Cited by 125
“One pilot study found that HIV+ smokers who received Public Health Service (PHS)-guided intervention were more likely to quit than a self-help control group (63% versus 0%) [22].”
BackgroundVidrine, D. J., Marks, R. M., Arduino, R. C., & Gritz, E. R. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr121 · Cited by 120
Metadata
- Authors
- Study, T. S. H. C., Battegay, M., Bernasconi, E., Böni, J., Bucher, H., Bürgisser, P., Cattacin, S., Cavassini, M., Dubs, R., Egger, M., Elzi, L., Erb, P., Fischer, M., Flepp, M., Fontana, A., Francioli, P., Furrer, H., Gorgievski, M., Günthard, H., Hirschel, B., Hösli, I., Kahlert, C., Kaiser, L., Karrer, U., Keiser, O., Kind, C., Klimkait, T., Ledergerber, B., Martinez, B., Müller, N., Nadal, D., Opravil, M., Paccaud, F., Pantaleo, G., Perrin, L., Bijker, J.-C., Rickenbach, M., Rudin, C., Schmid, P., Schultze, D., Schüpbach, J., Speck, R., Taffé, P., Tarr, P., Telenti, A., Trkola, A., Vernazza, P., Weber, R., Yerly, S., Elzi, L., Spoerl, D., Voggensperger, J., Nicca, D., Simcock, M., Bucher, H. C., Spirig, R., & Battegay, M.
- Venue
- Antiviral Therapy
- Publisher
- SAGE Publications
- Published
- 2006-08
- Volume
- 11
- Issue
- 6
- Pages
- 787-796
- ISSN
- 1359-6535 (ISSN-L)
- 2040-2058
- OpenAlex
- W2417562874
- Cited by
- 75
- References
- 7
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Smoking Cessation Programme in HIV-Infected Individuals: A Pilot Study. https://app.cochat.ai/papers/10.1177/135965350601100611
- The paper
- Study, T. S. H. C., Battegay, M., Bernasconi, E., Böni, J., Bucher, H., Bürgisser, P., Cattacin, S., Cavassini, M., Dubs, R., Egger, M., Elzi, L., Erb, P., Fischer, M., Flepp, M., Fontana, A., Francioli, P., Furrer, H., Gorgievski, M., Günthard, H., . . . Battegay, M. (2006). A Smoking Cessation Programme in HIV-Infected Individuals: A Pilot Study. Antiviral Therapy. https://doi.org/10.1177/135965350601100611
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.